ArticleAnnals of clinical and translational neurology2026

Safety and Efficacy of GLP-1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes.

Hyoshin Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.